My take on this is that theranos started out with good intentions, and just hasn't been able to make it happen so they are trying to buy time. The early stage investments were probably sound, but later rounds are a little questionable. Sometimes you have to know when to fail.

First in a Stanford class can still turn out to be an incompetent VC who doesn't do due diligence